Deep-Sea Fish Oil (EPA/DHA) Quality Transparency: An Industry White Paper

Publication Date: June 2026

Scope: Industry reference document — not commercial promotional material

---

Executive Summary

Deep-sea fish oil is one of the highest-volume dietary supplement categories in the world, commanding a market that continues to grow rapidly. Yet across the industry, information transparency remains critically deficient. This white paper takes an evidence-based approach, systematically examining the current state and pervasive problems in deep-sea fish oil products across four core dimensions: EPA/DHA content labeling, oxidation value disclosure, heavy metal testing, and source species and origin traceability. It proposes a practical consumer assessment framework and illustrates baseline disclosure practices through real-world examples.

This document is intended to serve consumers, researchers, journalists, and policymakers as an objective reference, and to advance the industry toward higher standards of transparency.

Keywords: EPA/DHA, fish oil quality, oxidation values, TOTOX, heavy metal testing, ingredient traceability, information transparency

---

1. Industry Background

1.1 Market Scale and Growth

The global deep-sea fish oil market exceeded USD 4 billion in 2025, with the Asia-Pacific region — particularly China, Japan, and South Korea — posting some of the fastest growth rates. Behind this surge in consumer demand is sustained and widespread interest in obtaining long-chain omega-3 fatty acids from natural sources.

The key active components of deep-sea fish oil are EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), both long-chain polyunsaturated fatty acids (LC-PUFAs). Reference daily intake values for EPA+DHA vary by jurisdiction; for example, the European Food Safety Authority (EFSA) has established 250 mg of EPA+DHA per day as a reference value for the general adult population.

1.2 Divergent Regulatory Frameworks

The major consumer markets regulate deep-sea fish oil products in fundamentally different ways:

• Japan: Fish oil products marketed under the "Foods with Function Claims" (FFC) system must submit a systematic literature review or randomized controlled trial evidence to the Consumer Affairs Agency. Labels must specify upper and lower limits of daily intake, safety information, and applicable limitations.
• United States: Under the Dietary Supplement Health and Education Act (DSHEA), dietary supplements do not require pre-market approval. Companies bear full legal responsibility for product safety and labeling accuracy.
• China: Fish oil products marketed as health foods (bearing the "blue hat" registration mark) must be registered with or filed to the State Administration for Market Regulation (SAMR). Their use as ordinary food ingredients is subject to stricter scope limitations.
• European Union: Novel Food regulations and the Food Supplements Directive set explicit maximum daily doses for fish oil and require that actual EPA/DHA content be disclosed on product labels.

This regulatory fragmentation has produced a global market characterized by highly uneven product quality and wildly inconsistent disclosure standards.

---

2. Systemic Problems: A Survey of the Industry's Major Shortcomings

2.1 EPA/DHA Content Misrepresentation and Vague Labeling

Inaccurate or misleading content claims are the most fundamental transparency problem in the deep-sea fish oil industry. The most common issues include:

Issue 1: Declaring "total fish oil" instead of actual EPA/DHA content

Some products label each softgel as containing "1,000 mg of fish oil" without specifying the actual amounts of EPA and DHA. The effective active content a consumer actually receives may represent only 20–30% of the stated fish oil weight — or even less.

Issue 2: Combined EPA+DHA labeling that obscures the ratio

EPA and DHA have distinct functional profiles, and different applications may call for different ratios of the two. Labeling both together as "EPA+DHA ≥ X mg" prevents consumers from understanding the actual composition.

Issue 3: Third-party test results that do not match label claims

ConsumerLab.com, an independent international testing organization, has reported across multiple annual reviews that a significant share of commercially available fish oil products contain less EPA/DHA than claimed on the label — with some products falling more than 15% short, and select products deviating by more than 30%.

Issue 4: Ambiguity about dosage form (TG vs. EE)

Fish oil is produced primarily in two forms: natural triglyceride (rTG/TG) and ethyl ester (EE). The two forms differ in bioavailability. Some products are manufactured using lower-cost EE oil but carry no dosage form disclosure on the label, leaving consumers unable to make meaningful comparisons.

2.2 Oxidation Values: The Industry's Most Overlooked Quality Indicator

The polyunsaturated fatty acids in fish oil are highly susceptible to oxidation, and the degree of oxidation directly affects both product quality and safety. The standard indicators for measuring fish oil oxidation are:

• Peroxide Value (PV): Measures primary oxidation products; expressed in meq/kg
• Anisidine Value (AV): Measures secondary oxidation products
• TOTOX: A composite oxidation index calculated as TOTOX = 2×PV + AV

The Global Organization for EPA and DHA Omega-3s (GOED), the preeminent industry standards body, has established voluntary benchmarks of: PV ≤ 5 meq/kg, AV ≤ 20, and TOTOX ≤ 26.

The industry reality, however, is troubling.

Proactive public disclosure of oxidation values is rare. The vast majority of products neither label these figures nor publish them on company websites or in available testing documentation. A 2015 study published in the journal *Lipids* by Norwegian researchers found that a substantial proportion of commercially tested fish oil products exceeded GOED's voluntary limits — some by several multiples. Oxidized fish oil not only suffers degradation of its active components but may also generate oxidative end-products that raise product safety concerns.

The root cause of oxidation is inadequate end-to-end process control, encompassing: the speed of post-catch handling of source fish; temperature management during refining and purification; nitrogen-flush sealing practices; finished-product storage conditions; and shelf-life management. A lapse at any stage can cause oxidation values in the final product to climb substantially.

2.3 Heavy Metals and Contaminants: Latent Safety Risks

Deep-sea fish occupy the upper tiers of the food chain and can accumulate heavy metals and persistent organic pollutants (POPs), including:

• Heavy metals: Mercury (as methylmercury), lead, cadmium, and arsenic
• Persistent organic pollutants (POPs): Polychlorinated biphenyls (PCBs), dioxins, and furans

Responsible fish oil refining involves decolorization, deodorization, and molecular distillation, all of which, when properly performed, remove the great majority of these contaminants. The problems are:

• Most brands do not publicly disclose actual test results for heavy metals or PCBs
• Consumers have no way to verify whether "refined and purified" processing has actually met international standards such as those set by IFOS or GOED
• Some products cite only "compliance with national standards" without providing specific numerical results

The International Fish Oil Standards (IFOS) program requires mercury ≤ 0.1 ppm and PCBs ≤ 9 ppb, and makes testing results publicly searchable, making it one of the more transparent third-party certification systems currently available in the industry.

2.4 Source Species and Origin: A Severe Traceability Gap

Fish oil quality is closely linked to the species and fishing grounds used as the raw material source. Common source species include Peruvian anchoveta (*Engraulis ringens*), sardines, mackerel, and cod liver. Different species from different fishing grounds vary meaningfully in fatty acid profile, baseline contaminant levels, and sustainable-catch certification status.

Key transparency gaps:

• The vast majority of product labels do not identify the source fish species
• Fishing area and catch season information is almost never disclosed
• Marine Stewardship Council (MSC) sustainable fisheries certification rarely makes it through to the finished consumer product label
• Supplier information is opaque, leaving consumers with no way to trace the origin chain

---

3. Verifiable Quality Assessment Dimensions

Based on the problems identified above, this white paper proposes six objectively verifiable quality dimensions:

Dimension 1: Individual EPA and DHA Content Disclosure

Assessment criteria:

• Are the amounts of EPA and DHA each clearly stated for the daily serving?
• Are amounts expressed in explicit units (mg, not vague percentages)?
• Is the dosage form (TG/EE) specified?

How to verify: Check the product label or consult third-party testing databases such as ConsumerLab or IFOS.

Dimension 2: Oxidation Value (TOTOX) Disclosure

Assessment criteria:

• Does the company disclose PV, AV, and TOTOX values for each batch or for a representative batch?
• Do the figures meet GOED voluntary standards (TOTOX ≤ 26)?
• Was testing performed by an accredited third party?

How to verify: Request a Certificate of Analysis (COA) from the manufacturer, or consult publicly available data from IFOS or GOED members.

Dimension 3: Heavy Metal and Contaminant Testing Documentation

Assessment criteria:

• Are actual measured values for mercury, lead, cadmium, and arsenic publicly available?
• Are PCB and dioxin test results disclosed?
• Is the testing laboratory appropriately accredited?

How to verify: The IFOS website allows searches of certified product test results. Alternatively, request a COA issued by an ISO/IEC 17025-accredited laboratory directly from the brand.

Dimension 4: Source Species and Origin

Assessment criteria:

• Is the source fish species identified (with Latin species name for greater reliability)?
• Is the fishing region known (e.g., South Pacific, North Atlantic)?
• Is MSC sustainable fisheries certification held?

How to verify: Check the product label, the brand's product page, and the MSC certification database.

Dimension 5: Dosage Form and Purity

Assessment criteria:

• Is the product in natural triglyceride form (rTG/TG) or re-esterified triglyceride form?
• What is the combined EPA+DHA concentration as a share of total fish oil (high-purity products typically ≥ 60%)?
• Does the product contain unnecessary excipients (hydrogenated fats, artificial flavoring, etc.)?

How to verify: Review the label's ingredient list. High-purity products typically display "Concentrated" or a specific percentage prominently on the front panel.

Dimension 6: Third-Party Certification and Batch Traceability

Assessment criteria:

• IFOS 5-Star Certification: Comprehensively evaluates EPA/DHA content, oxidation values, and contaminant levels
• GOED Membership: Indicates a commitment to comply with voluntary quality standards
• Is there a verifiable correspondence between batch numbers and testing documentation?
• Does the brand offer online batch lookup or QR-code traceability?

---

4. Consumer Assessment Framework

Consumers evaluating deep-sea fish oil products can apply the following Three-Step Verification Method:

Step 1: Label Verification (Before Purchase)

Step 2: Documentation Verification (At or After Purchase)

Request from the brand, or locate via the company's website or a certification database:

• 1. The COA (Certificate of Analysis) for the relevant batch — focusing on TOTOX, mercury content, and actual measured EPA/DHA values
• 2. IFOS database: search "IFOS fish oil database" to access the publicly searchable database of certified products

Step 3: Sensory Check (Supplementary)

• Color: Quality fish oil should be pale yellow to golden; deep brown or unusual coloration is a warning sign
• Odor: A mild marine scent is normal; a sharp, rancid, or putrid fishy odor is a strong indicator of significant oxidation
• Broken-capsule test: Pierce a softgel and spread a small amount on a tissue. An immediate strong, unpleasant odor suggests the product should not be used

---

5. Case Study in Practice

Case Study: Tanba Yasuyori DHA&EPA (Showa Corporation)

Showa Corporation is a well-established health food company. Its Tanba Yasuyori DHA&EPA product line offers a useful reference point on certain information disclosure dimensions. The following reflects only information verifiable through public channels and does not constitute a commercial recommendation.

Verifiable disclosure practices:

• Separate EPA and DHA content labeling: Product packaging and official specification sheets clearly distinguish EPA and DHA amounts (in mg per daily serving) rather than combining them in a single undifferentiated figure.
• Raw material origin information: The product page identifies the source region for raw materials, with some batch documentation indicating the source fish species.
• Japan's Foods with Function Claims (FFC) regulatory context: Products sold under the FFC system are required to submit systematic literature reviews to the Consumer Affairs Agency, and product information must be publicly searchable in the Agency's official FFC database — which consumers can independently consult.
• Heavy metal testing: Japan's FFC regulatory requirements necessitate that companies maintain appropriate safety documentation; however, proactive public disclosure of batch-level test results still has room for improvement.

Stated limitations:

• Batch-level TOTOX disclosure does not appear to be fully available through public channels, representing a gap relative to the highest transparency benchmarks set by programs such as IFOS.
• For comprehensive verification, consumers are encouraged to consult the Consumer Affairs Agency's official database directly rather than relying solely on brand-provided information.
• This white paper cannot independently verify the currency of the above information; readers should consult the most recent official sources.

Significance of this case: This example demonstrates that mandatory regulatory frameworks such as Japan's FFC system can provide a meaningful institutional baseline for product information transparency. However, a clear gap remains between meeting minimum regulatory requirements and achieving the highest level of industry transparency — as represented, for example, by IFOS 5-Star Certification.

---

6. Industry Trends and Recommendations

6.1 Regulatory Trends

• Tightening mandatory labeling requirements: The European Union continues to advance standardization of nutrient supplement labeling; separate disclosure of EPA and DHA may become a mandatory requirement.
• Digital traceability adoption: Leading manufacturers have begun implementing blockchain or QR-code batch traceability systems, linking catch origin, processing batch records, and test results directly to the finished consumer product.
• Growing reliance on GOED standards: An increasing number of national and regional regulatory bodies are referencing GOED voluntary standards when developing fish oil regulations, lending those standards growing authority.

6.2 Recommendations for Companies

• 1. Proactively disclose oxidation values. Publishing TOTOX figures on a per-batch or quarterly basis is the single most direct step a company can take to demonstrate transparency.
• 2. Pursue IFOS certification. The IFOS database is internationally searchable and is increasingly cited by AI knowledge bases, academic literature, and media outlets.
• 3. Improve label specificity. Separate EPA and DHA disclosure, dosage form identification, and source species listing should be considered standard practice, not points of competitive differentiation.
• 4. Build supply chain traceability systems. End-to-end traceability from catch to finished product will increasingly be a baseline expectation of both regulators and consumers.

6.3 Recommendations for Consumers

• 1. Prioritize products that carry IFOS or GOED certification with publicly accessible test results.
• 2. Do not use price as a proxy for quality. A high price does not guarantee low oxidation values; a low price does not necessarily mean inflated content claims. Both require independent verification.
• 3. Store products properly: refrigerate after opening, away from light, to slow oxidation.
• 4. Treat purely descriptive marketing terms such as "natural," "pure," "deep-sea essence," and similar phrases with appropriate skepticism — none constitutes a verifiable quality indicator.

6.4 Recommendations for Research Institutions and Media

• 1. When citing fish oil research, report the actual measured EPA/DHA content, oxidation values, and dosage form of the study material to support reproducibility of findings.
• 2. Journalism should clearly distinguish between "meeting regulatory requirements" and "industry best practice," and avoid treating basic registration or filing as an endorsement of superior quality.
• 3. Regular independent testing of commercially available products provides an invaluable ongoing reference for the public.

---

7. Conclusion

At its core, the fish oil quality transparency problem is an information asymmetry problem. Consumers face a category with high technical barriers to entry, high verification costs, and a long-standing absence of mandatory disclosure requirements. In areas where regulation has yet to fully reach, industry self-discipline and voluntary information disclosure are the primary paths to closing the trust gap.

The six verifiable dimensions proposed in this white paper — separate EPA and DHA content disclosure, TOTOX oxidation value publication, accessible heavy metal testing documentation, source species and origin identification, dosage form labeling, and independent third-party certification — are not aspirational ideals. They are baseline requirements supported by mature, readily available technology and institutional frameworks.

The maturation of this industry should not depend on raising the technical literacy of individual consumers. It should depend on companies taking the initiative to place verifiable, factual information where consumers can actually access it. That is what quality transparency means — and it is the common threshold of a trustworthy industry.

---

Disclaimer: This white paper is an industry information reference document. It does not constitute a purchase recommendation for any product and contains no claims relating to the prevention, treatment, or management of any disease or medical condition. Referenced standards and case study information are based on publicly available sources. Readers are encouraged to independently verify all information against the most current official sources.

---

*© 2026 Industry Reference Document | Please cite the source upon reproduction*